Cargando…

Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease

PURPOSE: Pediatric Crohn's disease (CD) is directly related to growth and has a high probability of requiring surgical intervention(s); therefore, more active treatment for CD is required for children. This study investigated the impact of biologics on growth and disease course associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Min Hyung, Cho, Young Hoon, Sohn, Min Ji, Lee, Eun Joo, Kim, Ju Whi, Moon, Jin Soo, Ko, Jae Sung, Kim, Hyun-young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629593/ https://www.ncbi.nlm.nih.gov/pubmed/31338311 http://dx.doi.org/10.5223/pghn.2019.22.4.358

Ejemplares similares

Effect of the Baseline Vitamin D Level on Growth Outcome in Pediatric Crohn Disease
por: Lee, Eun Joo, et al.
Publicado: (2017)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
por: Kang, Dong Hyuk, et al.
Publicado: (2011)

α-Blocker Monotherapy and α-Blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years' Long-Term Results
por: Shin, Teak Jun, et al.
Publicado: (2012)

Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?
por: Kim, Sung Jin, et al.
Publicado: (2022)

Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease
por: Kim, Sun, et al.
Publicado: (2021)

Prospective Factor Analysis of Alpha Blocker Monotherapy Failure in Benign Prostatic Hyperplasia
por: Hong, Kyoung Pyo, et al.
Publicado: (2010)

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

Prolonged paradoxical reaction to anti-tuberculous treatment after discontinuation of TNF-alpha- blocker therapy with adalimumab. Rare clinical documentation
por: Falkenstern-Ge, Roger Fei, et al.
Publicado: (2014)

CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)

High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis
por: Moon, Dong-Hyuk, et al.
Publicado: (2023)

Efficacy of Alpha Blocker Treatment According to the Degree of Intravesical Prostatic Protrusion Detected by Transrectal Ultrasonography in Patients with Benign Prostatic Hyperplasia
por: Park, Hee Young, et al.
Publicado: (2012)

Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment
por: Sanchis-Artero, Laura, et al.
Publicado: (2021)

Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
por: Unlu, Mehmet, et al.
Publicado: (2014)

Multiple Autoimmune Skin Manifestations in a Patient with Crohn's Disease Treated with a Tumor Necrosis Factor-Alpha Blocker
por: Zattra, Edoardo, et al.
Publicado: (2015)

Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease
por: Ko, Kyoung Ho, et al.
Publicado: (2019)

Bladder Wall Thickness is Associated with Responsiveness of Storage Symptoms to Alpha-Blockers in Men with Lower Urinary Tract Symptoms
por: Park, Jung Soo, et al.
Publicado: (2012)

Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report
por: Bokemeyer, Arne, et al.
Publicado: (2018)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
por: Fonseca, Ashley, et al.
Publicado: (2021)

Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
por: van der Houwen, Tim, et al.
Publicado: (2020)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Hydrochloric acid-treated Bacillus subtilis ghosts induce IL-1 beta, IL-6, and TNF-alpha in murine macrophage
por: Kim, Young-Min, et al.
Publicado: (2022)

The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease
por: Lee, Chan Hyung, et al.
Publicado: (2020)

TNFα Induces LGR5+ Stem Cell Dysfunction In Patients With Crohn’s Disease
por: Lee, Chansu, et al.
Publicado: (2021)

Metronidazole-induced encephalopathy in a patient with Crohn's disease
por: Kim, Jihye, et al.
Publicado: (2017)

Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn’s Disease
por: Kwak, Min Seob, et al.
Publicado: (2022)

Dose-Response Effect of Daily Rehabilitation Time on Functional Gain in Stroke Patients
por: Ko, Hanbit, et al.
Publicado: (2020)

The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study
por: Scarpa, Raffaele, et al.
Publicado: (2011)

Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis
por: Gu, Ki-Nam, et al.
Publicado: (2019)

ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis
por: Hahn, Jong Woo, et al.
Publicado: (2022)

Development of primary malignant melanoma during treatment with a TNF-α antagonist for severe Crohn’s disease: a case report and review of the hypothetical association between TNF-α blockers and cancer
por: Kouklakis, George, et al.
Publicado: (2013)

Risk Factors Leading to Anti-TNF Alpha Therapies in Pediatric Severe Uveitis
por: Osswald, Delphine, et al.
Publicado: (2022)

A Novel Homozygous LIPA Mutation in a Korean Child with Lysosomal Acid Lipase Deficiency
por: Kim, Kwang Yeon, et al.
Publicado: (2017)

The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis
por: Machado, Natalia P., et al.
Publicado: (2013)

Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab
por: Kim, Young Ho, et al.
Publicado: (2020)

Development of a Machine Learning Model to Predict Non-Durable Response to Anti-TNF Therapy in Crohn’s Disease Using Transcriptome Imputed from Genotypes
por: Park, Soo Kyung, et al.
Publicado: (2022)

Prescription pattern of alpha-blockers for management of lower urinary tract symptoms/benign prostatic hyperplasia
por: Moon, Hyong Woo, et al.
Publicado: (2018)

Alveolar Macrophages Play a Key Role in Cockroach-Induced Allergic Inflammation via TNF-α Pathway
por: Kim, Joo Young, et al.
Publicado: (2012)

Relationship between Vagal Tone, Cortisol, TNF-Alpha, Epinephrine and Negative Affects in Crohn’s Disease and Irritable Bowel Syndrome
por: Pellissier, Sonia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g4228gm504ddhkrgbrf0uig9n8